BURLINGTON, ON, Aug 8, 2022
/CNW/ - EcoSynthetix Inc. (TSX: ECO) ("EcoSynthetix" or the
"Company"), a renewable chemicals company that produces a
portfolio of commercially proven bio-based products, today
announced its financial and operational results for the three
months (Q2 2022) and six months (YTD 2022) ended June 30, 2022. Financial references are in U.S.
dollars unless otherwise indicated.
Highlights
(Comparison periods in each case
are the three months ended June 30,
2021)
- Recorded net sales of $4.2
million in Q2 2022, down 15%, due to lower volumes of 43%,
partly offset by higher average selling price of 28%
- Continued diversification of revenue mix as applications beyond
traditional graphic paper represented a greater portion of revenue
which supported an improved margin profile despite inflationary
pressures
- The Company's personal care joint development partner, Dow
Chemical Company, announced an exclusive engagement with
EcoSynthetix targeting the hairstyling market with MaizeCare™
Polymers, a bio-based and biodegradable technology that provides
unique and high-performance benefits
- Gross profit of $1.1 million,
unchanged, enabled by the higher average selling price which offset
a decline in sales volumes
- Recorded an Adjusted EBITDA1 loss of $0.2 million in Q2 2022, unchanged from the prior
period
- Purchased and cancelled 90,500 common shares in Q2 2022 under
the normal course issuer bid for total consideration of
$0.4 million
- Maintained a strong balance sheet with cash and term deposits
of $39.4 million as at June 30, 2022
- Named one of the Best 50 Corporate Citizens in Canada by Corporate Knights, ranking
20th overall in Corporate Knights' transparent,
quantitative methodology that places equal emphasis on the ESG
performance of a company's operations and the environmental impact
of its core products
"Our diversification strategy into wood composites, personal
care and wet-end paper strengthening aids made meaningful
contributions to results in the quarter. We saw good progress
across our key strategic wood composites account, the new wet-end
paper application and in the MaizeCare offering during the
quarter," said Jeff MacDonald, CEO
of EcoSynthetix. "Sales volumes were impacted by challenging macro
conditions which included supply chain and logistics constraints
for raw materials, inflationary pressures and further deterioration
of demand in the graphic paper market. The availability of raw
materials and logistics constraints resulted in an estimated
$0.5 million to $1 million impact to net sales in the quarter.
While those constraints remain, we are seeing the first positive
signals of a more balanced raw materials environment. The
sustainability profile of our bio-based polymer technology,
together with its compelling value and performance attributes are
gaining greater interest across a diverse base of accounts which
set the stage for long-term growth."
Financial Summary
Net Sales
Net sales were $4.2 million and
$8.4 million for Q2 2022 and YTD
2022, respectively, compared to $4.9
million and $8.6 million for
the corresponding periods in 2021. The decreases were due to lower
sales volumes partly offset by higher average selling price. The
15% decrease in the quarter was due to lower sales volumes of
$2.1 million, or 43%, due to
unfavorable market conditions in graphic paper and limited
feedstock availability due to challenging supply chain conditions.
This decline includes a $0.6 million
headwind in the quarter related to the closure of a paper mill that
was announced in the third quarter of 2021. These pressures were
partially offset by higher selling price and improved product mix
which increased sales $1.4 million,
or 28%, as the Company was able to offset significant inflationary
pressures with price increases.
Gross Profit
Gross profit was $1.1 million and
$2.2 million for Q2 2022 and YTD
2022, respectively, compared to $1.1
million and $1.9 million for
the corresponding periods in 2021. During both periods, a higher
average selling price and an improved product mix was offset by
decreases in sales volumes and higher manufacturing costs.
Gross profit as a percentage of sales was 26.8% and 26.1% for Q2
2022 and YTD 2022, respectively, compared to 22.5% and 21.6% for
the corresponding periods in 2021. Gross profit as a percentage of
sales adjusted for manufacturing depreciation was 30.8% and 29.8%
for Q2 2022 and YTD 2022, respectively, compared to 26.3% and 26.2%
for the corresponding periods in 2021. The improvements in both
periods were primarily due to a higher average selling price and an
improved product mix partly offset by higher manufacturing
costs.
Selling, General and Administrative
Selling, general and administrative expenses (SG&A) were
$1.4 million and $2.7 million for Q2 2022 and YTD 2022,
respectively, compared to $1.3
million and $2.5 million for
the corresponding periods in 2021. The increase in SG&A during
Q2 2022 was primarily due to higher operating costs of $0.3 million including lower payments received
under the Canadian Emergency Wage Subsidy program (CEWS), foreign
exchange loss and increased discretionary spend, which was
partially offset by a reduction in the provision for variable
compensation of $0.2 million.
Research and Development
Research and development (R&D) costs were $0.5 million and $0.9
million for Q2 2022 and YTD 2022, respectively, which were
in line with $0.6 million and
$0.9 million in the corresponding
periods in 2021. R&D expense as a percentage of sales were 12%
and 11% for Q2 2022 and YTD 2022, respectively, compared to 11% and
10% in the corresponding periods in 2021. The Company's R&D
efforts continue to focus on further enhancing value for our
existing products and expanding addressable opportunities.
Adjusted EBITDA1
Adjusted EBITDA loss was $0.2
million and $0.4 million for
Q2 2022 and YTD 2022, respectively, which was in line with
$0.2 million and $0.5 million during the corresponding same
periods in 2021. The improvements were due to higher gross profit
in both periods partly offset by higher operating costs which
resulted in negligible changes compared to the prior year
periods.
Net Loss
Net loss was $0.7 million, or
$0.01 per common share, and
$1.3 million, or $0.02 per common share, for Q2 2022 and YTD 2022,
respectively, compared to $0.7
million, or $0.01 per common
share, and $1.5 million, or
$0.03 per common share, for the
corresponding periods in 2021. The change in the YTD period was
primarily due to lower loss from operations and higher interest
income.
Liquidity
Cash on hand and term deposits were $39.4
million as at June 30, 2022,
compared to $42.2 million as at
December 31, 2021. The Company
purchased and cancelled 90,000 and 227,600 common shares under the
normal course issuer bid during the Q2 2022 and YTD 2022 periods,
respectively, for consideration of $0.4
million and $1.0 million.
Notice of Conference Call
EcoSynthetix will host a conference call Tuesday, August 9, 2022, at 8:30 AM ET to discuss its financial results.
Jeff MacDonald, CEO, and
Robert Haire, CFO, will co-chair the
call. All interested parties can join the call by dialling (647)
484-0475 or (888) 394-8218 with the conference identification of
9879897. Please dial in 15 minutes prior to the call to secure a
line. A live audio webcast of the conference call will also be
available at www.ecosynthetix.com. The presentation will be
accompanied by slides, which will be available via the webcast link
and the Company's website. Please connect at least 15 minutes prior
to the conference call to ensure adequate time for any software
download that may be required to join the webcast.
1Non-IFRS Financial Measures
This press release makes reference to certain non-IFRS measures.
These non-IFRS measures are not recognized measures under IFRS, do
not have a standardized meaning prescribed by IFRS and are
therefore unlikely to be comparable to similar measures presented
by other companies. Rather, these measures are provided as
additional information to complement those IFRS measures by
providing a further understanding of results of operations of
EcoSynthetix from management's perspective. Accordingly, they
should not be considered in isolation nor as a substitute for
analysis of the financial information of EcoSynthetix reported
under IFRS. The Company uses non-IFRS measures such as Adjusted
EBITDA to provide investors with a supplemental measure of
operating performance and thus highlight trends in its core
business that may not otherwise be apparent when relying solely on
IFRS financial measures. Management also believes that securities
analysts, investors and other interested parties frequently use
non-IFRS measures in the evaluation of issuers. Management also
uses non-IFRS measures in order to facilitate operating performance
comparisons from period to period, prepare annual operating budgets
and assess the Company's ability to meet its capital expenditure
and working capital requirements.
Adjusted EBITDA is not a measure recognized under IFRS and does
not have a standardized meaning prescribed by IFRS. See "IFRS and
Non-IFRS Measures." The Company presents Adjusted EBITDA because
the Company believes it facilitates investors' use of operating
performance comparisons from period to period and company to
company by backing out potential differences caused by variations
in capital structures (affecting relative interest expense), the
book amortization of intangibles (affecting relative amortization
expense) and the age and book value of property and equipment
(affecting relative depreciation expense). The Company also
presents Adjusted EBITDA because it believes it is frequently used
by securities analysts, investors and other interested parties as a
measure of financial performance. Adjusted EBITDA as presented
herein are not recognized measures under IFRS and should not be
considered as an alternative to operating income or net income as
measures of operating results or an alternative to cash flows as
measures of liquidity. Adjusted EBITDA is defined as consolidated
net income (loss) before net interest expense, income taxes,
depreciation, amortization, other non-cash expenses and charges
deducted in determining consolidated net income (loss).
The following table reconciles net loss to Adjusted EBITDA loss
for the three months and six months ended June 30, 2022 and June 30,
2021:
|
Three months
ended
June 30, 2022
|
Three months
ended
June 30, 2021
|
Six months ended
June 30, 2022
|
Six months ended
June 30, 2021
|
Net Loss
|
(676,828)
|
(729,097)
|
(1,335,720)
|
(1,478,981)
|
Depreciation
|
280,307
|
338,417
|
512,859
|
698,543
|
Share-based
Compensation
|
251,301
|
227,485
|
523,267
|
346,962
|
Interest
Income
|
(82,499)
|
(15,669)
|
(114,986)
|
(41,610)
|
Adjusted EBITDA
loss
|
(227,719)
|
(178,864)
|
(414,580)
|
(475,086)
|
About EcoSynthetix Inc. (www.ecosynthetix.com)
EcoSynthetix, a 2022 climate positive company, offers a range of
sustainable engineered biopolymers that allow customers to reduce
their use of harmful materials, such as formaldehyde and
styrene-based chemicals. The Company's flagship products,
DuraBind™, Bioform™, and EcoSphere®, are used to manufacture wood
composites, personal care, and paper and packaging, and enable
performance improvements, economic benefits and carbon footprint
reduction. The Company is publicly traded on the Toronto Stock
Exchange (T:ECO).
Forward-Looking Statements
Certain statements in this Press Release constitute
"forward-looking" statements that involve known and unknown risks,
uncertainties and other factors which may cause the actual results,
performance, objectives or achievements of the Company, or industry
results, to be materially different from any future results,
performance, objectives or achievements expressed or implied by
such forward looking statements. The forward-looking statements in
this Press Release include, but are not limited to, statements
regarding the Company's plans to execute its commercial strategy,
deliver meaningful growth across all three product categories,
convert high-value strategic prospects into customers, and other
statements regarding the Company's plans and expectations in 2022.
These statements reflect our current views regarding future events
and operating performance and are based on information currently
available to us, and speak only as of the date of this Press
Release. These forward-looking statements involve a number of
risks, uncertainties and assumptions and should not be read as
guarantees of future performance or results, and will not
necessarily be accurate indications of whether or not such
performance or results will be achieved. Those assumptions and
risks include, but are not limited to, the Company's ability to
successfully allocate capital as needed and to develop new
products, as well as the fact that our results of operations and
business outlook are subject to significant risk, volatility and
uncertainty. Many factors could cause our actual results,
performance or achievements to be materially different from any
future results, performance or achievements that may be expressed
or implied by such forward-looking statements, including the
factors identified in the "Risk Factors" section of the Company's
Annual Information Form dated February 24,
2022. Should one or more of these risks or uncertainties
materialize, or should assumptions underlying the forward-looking
statements prove incorrect, actual results may vary materially from
those described in this Press Release as intended, planned,
anticipated, believed, estimated or expected. Unless required by
applicable securities law, we do not intend and do not assume any
obligation to update these forward-looking statements.
EcoSynthetix
Inc.
|
|
|
Interim Consolidated
Balance Sheets
|
|
|
(expressed in US
dollars)
|
|
|
|
|
|
|
|
|
|
June 30,
2022
|
December 31,
2021
|
Assets
|
|
|
|
|
|
Current
assets
|
|
|
Cash
|
19,292,852
|
42,226,816
|
Term
deposits
|
5,015,343
|
-
|
Accounts
receivable
|
1,703,506
|
1,912,390
|
Inventory
|
2,768,728
|
2,073,800
|
Government grants
receivable
|
16,554
|
6,676
|
Prepaid
expenses
|
163,303
|
91,930
|
|
28,960,286
|
46,311,612
|
|
|
|
Non-current
assets
|
|
|
Term
deposits
|
15,091,178
|
-
|
Property, plant and
equipment
|
4,342,153
|
4,670,089
|
|
19,433,331
|
4,670,089
|
|
|
|
Total
assets
|
48,393,617
|
50,981,701
|
|
|
|
|
|
|
Liabilities
|
|
|
|
|
|
Current
liabilities
|
|
|
Trade accounts payables
and accrued liabilities
|
1,736,579
|
2,363,630
|
|
|
|
Non-current
liabilities
|
|
|
Lease
liability
|
673,681
|
820,045
|
|
|
|
Total
liabilities
|
2,410,260
|
3,183,675
|
Shareholders'
Equity
|
|
|
Common
shares
|
491,458,321
|
492,297,041
|
Contributed
surplus
|
10,211,762
|
9,851,991
|
Accumulated
deficit
|
(455,686,726)
|
(454,351,006)
|
Total shareholders'
equity
|
45,983,357
|
47,798,026
|
|
|
|
Total liabilities
and shareholders' equity
|
48,393,617
|
50,981,701
|
EcoSynthetix
Inc.
|
|
|
|
|
|
Interim Consolidated
Statements of Operations and Comprehensive Loss
|
|
|
|
|
|
For the three and
six months ended June 30, 2022 and 2021
|
|
|
|
|
|
(expressed in US
dollars)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months
ended June 30,
|
|
Six months
ended June 30,
|
|
2022
|
2021
|
|
2022
|
2021
|
|
|
|
|
|
|
Net
sales
|
4,167,838
|
4,897,107
|
|
8,405,793
|
8,570,554
|
|
|
|
|
|
|
Cost of
sales
|
3,050,353
|
3,794,621
|
|
6,208,268
|
6,715,979
|
|
|
|
|
|
|
Gross profit on
sales
|
1,117,485
|
1,102,486
|
|
2,197,525
|
1,854,575
|
|
|
|
|
|
|
Expenses
|
|
|
|
|
|
Selling, general and
administrative
|
1,375,381
|
1,294,822
|
|
2,716,066
|
2,493,811
|
Research and
development
|
501,431
|
552,430
|
|
932,165
|
881,355
|
|
1,876,812
|
1,847,252
|
|
3,648,231
|
3,375,166
|
|
|
|
|
|
|
Loss from
operations
|
(759,327)
|
(744,766)
|
|
(1,450,706)
|
(1,520,591)
|
|
|
|
|
|
|
Net interest
income
|
82,499
|
15,669
|
|
114,986
|
41,610
|
|
|
|
|
|
|
Net loss and
comprehensive loss
|
(676,828)
|
(729,097)
|
|
(1,335,720)
|
(1,478,981)
|
|
|
|
|
|
|
Basic and diluted
loss per common share
|
(0.01)
|
(0.01)
|
|
(0.02)
|
(0.03)
|
|
|
|
|
|
|
Weighted average
number of common shares outstanding
|
58,855,891
|
57,241,838
|
|
58,895,397
|
57,248,524
|
EcoSynthetix
Inc.
|
|
|
|
|
|
Interim Consolidated
Statements of Cash Flows
|
|
|
|
|
|
For the three and
six months ended June 30, 2022 and 2021
|
|
|
|
|
|
(expressed in US
dollars)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months
ended June 30,
|
|
Six months
ended June 30,
|
|
2022
|
2021
|
|
2022
|
2021
|
Cash provided by
(used in)
|
|
|
|
|
|
|
|
|
|
|
|
Operating
activities
|
|
|
|
|
|
Net loss and
comprehensive loss
|
(676,828)
|
(729,097)
|
|
(1,335,720)
|
(1,478,981)
|
Items not affecting
cash
|
|
|
|
|
|
Depreciation
|
280,307
|
338,417
|
|
512,859
|
698,543
|
Share-based
compensation
|
251,301
|
227,485
|
|
523,267
|
346,962
|
Other
|
58,713
|
62,960
|
|
10,536
|
66,854
|
Changes in non-cash
working capital
|
|
|
|
|
|
Accounts
receivable
|
200,075
|
(12,573)
|
|
208,884
|
(206,897)
|
Inventory
|
134,242
|
(70,123)
|
|
(671,744)
|
(543,844)
|
Government grants
receivable
|
(3,158)
|
71,161
|
|
(9,878)
|
68,288
|
Prepaid expenses
|
(116,448)
|
(62,709)
|
|
(71,373)
|
(35,186)
|
Trade accounts payables and
accrued liabilities
|
9,738
|
(59,767)
|
|
(644,389)
|
873,415
|
Interest on term
deposits
|
|
|
|
|
|
Interest received on term deposits
|
-
|
-
|
|
-
|
358,740
|
Accrued interest on term deposits
|
(60,584)
|
-
|
|
(106,521)
|
(14,165)
|
|
77,358
|
(234,246)
|
|
(1,584,079)
|
133,729
|
|
|
|
|
|
|
Investing
activities
|
|
|
|
|
|
Purchase of property,
plant and equipment
|
(148,924)
|
(193,791)
|
|
(198,486)
|
(238,348)
|
Receipts on mature
short-term investments
|
-
|
-
|
|
-
|
25,000,000
|
Purchase of term
deposits
|
-
|
-
|
|
(20,000,000)
|
-
|
|
(148,924)
|
(193,791)
|
|
(20,198,486)
|
24,761,652
|
|
|
|
|
|
|
Financing
activities
|
|
|
|
|
|
Payments made on lease
liability
|
(70,354)
|
(62,958)
|
|
(131,635)
|
(122,195)
|
Common shares
repurchased
|
(388,603)
|
(207,898)
|
|
(1,002,216)
|
(397,893)
|
Exercise of common
share options
|
-
|
28,118
|
|
-
|
220,093
|
|
(458,957)
|
(242,738)
|
|
(1,133,851)
|
(299,995)
|
|
|
|
|
|
|
|
|
|
|
|
|
Effect of exchange rate
changes on cash
|
(80,087)
|
(40,661)
|
|
(17,548)
|
(28,958)
|
|
|
|
|
|
|
Change in cash
during the period
|
(610,610)
|
(711,436)
|
|
(22,933,964)
|
24,566,428
|
|
|
|
|
|
|
Cash - Beginning of
period
|
19,903,462
|
41,915,025
|
|
42,226,816
|
16,637,161
|
|
|
|
|
|
|
Cash - End of
period
|
19,292,852
|
41,203,589
|
|
19,292,852
|
41,203,589
|
SOURCE EcoSynthetix Inc.